CAPA - What does the FDA expect from Medical Devices Manufacturers?
Recommendation

17/18 June 2026
Copenhagen, Denmark
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
Deficiencies with regard to CAPA (Corrective and Preventive Action) are regularly Top 1 in FDA's Warning Letter statistics (see our GMP News from 23 September 2014). The FDA has just recently published presentations in form of webinars on the following topics:
- Investigational Device Exemption (IDE) Program
- 510(k) Program
- Corrective and Preventive Actions (CAPA)
- Electronic Medical Device Reporting (eMDR)
The 31 slides on CAPA are particularly interesting and aim to:
- Explain the objective of CAPA
- Differentiate individual terms like Correction, Corrective Action, Preventive Action
- Clarify the requirements from the Quality System Regulations 21 CFR 820 (GMP for Medical Devices)
- Present diverse "Tools"
and
- Show examples and "Best Practices"
There is even the possibility to have a look at the webinar's slides "Corrective and Preventive Action Basics".
Related GMP News
27.05.2026Survey Results from Team Notified Body on the MDR and IVDR
27.05.2026FDA Q&A Document on the new GMP Regulations for Medical Devices
27.05.2026CDRH Annual Report 2025
13.01.2026MDCG publishes Guidance on the Surveillance of Medical Devices and IVDs
13.01.2026Real-world Evidence Data now also expanded in the Field of Medical Devices
06.11.2025FDA Warning Letter Statistics on Medical Devices in the Past Fiscal Year 2025


